These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 31279904)

  • 1. Prevalence of prediabetes and diabetes in children and adolescents with biopsy-proven non-alcoholic fatty liver disease.
    Nobili V; Mantovani A; Cianfarani S; Alisi A; Mosca A; Sartorelli MR; Maffeis C; Loomba R; Byrne CD; Targher G
    J Hepatol; 2019 Oct; 71(4):802-810. PubMed ID: 31279904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease.
    Newton KP; Hou J; Crimmins NA; Lavine JE; Barlow SE; Xanthakos SA; Africa J; Behling C; Donithan M; Clark JM; Schwimmer JB;
    JAMA Pediatr; 2016 Oct; 170(10):e161971. PubMed ID: 27478956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of Prediabetes Among Adolescents and Young Adults in the United States, 2005-2016.
    Andes LJ; Cheng YJ; Rolka DB; Gregg EW; Imperatore G
    JAMA Pediatr; 2020 Feb; 174(2):e194498. PubMed ID: 31790544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic Measures and Development and Resolution of Nonalcoholic Fatty Liver Disease in Nondiabetic Individuals.
    Wang B; Li M; Zhao Z; Wang S; Lu J; Chen Y; Xu M; Wang W; Ning G; Bi Y; Wang T; Xu Y
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32144419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD).
    Cuthbertson DJ; Koskinen J; Brown E; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
    Ann Med; 2021 Dec; 53(1):1256-1264. PubMed ID: 34309471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study.
    Ming J; Xu S; Gao B; Liu G; Ji Y; Yang F; Jia Y; Fang Y; Ji Q
    Liver Int; 2015 Nov; 35(11):2401-7. PubMed ID: 25879672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased risks of different grades of non-alcoholic fatty liver disease in prediabetic subjects with impaired fasting glucose and glucose tolerance, including the isolated glycosylated hemoglobin levels of 5.7-6.4% in a Chinese population.
    Li CH; Chou YT; Shen WC; Lu FH; Yang YC; Wu JS; Chang CJ
    J Diabetes Investig; 2020 Sep; 11(5):1336-1343. PubMed ID: 32270583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
    Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
    World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabesity phenotype in relation to the incidence and resolution of nonalcoholic fatty liver disease: A prospective cohort study.
    Kong L; Ye C; Wang Y; Dou C; Zheng J; Wang S; Lin H; Zhao Z; Li M; Xu Y; Chen Y; Lu J; Xu M; Wang W; Ning G; Bi Y; Wang T
    J Diabetes; 2024 Jan; 16(1):e13459. PubMed ID: 37584361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical validation of the FLIP algorithm and the SAF score in patients with non-alcoholic fatty liver disease.
    Nascimbeni F; Bedossa P; Fedchuk L; Pais R; Charlotte F; Lebray P; Poynard T; Ratziu V;
    J Hepatol; 2020 May; 72(5):828-838. PubMed ID: 31862486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SCCA-IgM as a Potential Biomarker of Non-Alcoholic Fatty Liver Disease in Patients with Obesity, Prediabetes and Diabetes Undergoing Sleeve Gastrectomy.
    Bettini S; Bordigato E; Milan G; Dal Pra' C; Favaretto F; Belligoli A; Sanna M; Serra R; Foletto M; Prevedello L; Busetto L; Fassina G; Vettor R; Fabris R
    Obes Facts; 2019; 12(3):291-306. PubMed ID: 31104052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence, risk factors, and screening measure for prediabetes and diabetes among Emirati overweight/obese children and adolescents.
    Al Amiri E; Abdullatif M; Abdulle A; Al Bitar N; Afandi EZ; Parish M; Darwiche G
    BMC Public Health; 2015 Dec; 15():1298. PubMed ID: 26704130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Haemoglobin A1c in Screening Obese Children and Adolescents for Glucose Intolerance and Type 2 Diabetes.
    Galhardo J; Shield J
    Acta Med Port; 2015; 28(3):307-15. PubMed ID: 26421782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of fatty pancreas on serum glucose parameters in patients with nonalcoholic steatohepatitis.
    Uygun A; Kadayifci A; Demirci H; Saglam M; Sakin YS; Ozturk K; Polat Z; Karslioglu Y; Bolu E
    Eur J Intern Med; 2015 Jan; 26(1):37-41. PubMed ID: 25491010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the Relationship Between Metabolic Syndrome and Liver Biopsy-Proven Non-Alcoholic Steatohepatitis in China: A Multicenter Cross-Sectional Study Design.
    Xu ZJ; Shi JP; Yu DR; Zhu LJ; Jia JD; Fan JG
    Adv Ther; 2016 Nov; 33(11):2069-2081. PubMed ID: 27743352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mean and visit-to-visit variability of glycated hemoglobin, and the risk of non-alcoholic fatty liver disease.
    Yoo JH; Kang M; Kim G; Hur KY; Kim JH; Sinn DH; Jin SM
    J Diabetes Investig; 2021 Jul; 12(7):1252-1262. PubMed ID: 33135331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Morbidity and Comorbidity of Nonalcoholic Fatty Liver Disease and Different Glucose Intolerance Strata in a Community-Based Chinese Population.
    Zhang X; Zhou X; Han X; Fu Z; Wang L; Li Y; Ji L
    Metab Syndr Relat Disord; 2020 Aug; 18(6):284-290. PubMed ID: 32460629
    [No Abstract]   [Full Text] [Related]  

  • 20. Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes.
    Scapaticci S; D'Adamo E; Mohn A; Chiarelli F; Giannini C
    Front Endocrinol (Lausanne); 2021; 12():639548. PubMed ID: 33889132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.